Literature DB >> 11122499

Future directions of research in statistical genetics.

S Horvath1, M P Baur.   

Abstract

From a global perspective, two external developments are having dramatic effects upon the field of statistical genetics: improved genetic data, for example, human DNA sequence, and new technologies, for example, microarray technology. Meiotic mapping techniques will have to be adapted to benefit from the improved data, for example, allelic association studies have to be extended to multiple markers to profit from the new genetic map of SNP markers. Changing technology has led to ever-increasing knowledge about gene function which has enabled novel gene mapping strategies which we refer to as functional mapping. Functional mapping has great potential for mapping complex disease genes since it uses pathway fractions to intermediate between genotype and phenotype information. Methods used in whole-genome gene expression studies are used to illustrate concepts of functional mapping. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11122499     DOI: 10.1002/1097-0258(20001230)19:24<3337::aid-sim828>3.0.co;2-3

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Biomarker identification by feature wrappers.

Authors:  M Xiong; X Fang; J Zhao
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

2.  A family-based test for correlation between gene expression and trait values.

Authors:  Peter Kraft; Eric Schadt; Jason Aten; Steve Horvath
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

3.  Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia.

Authors:  Marquis P Vawter; Mary E Atz; Brandi L Rollins; Kathleen M Cooper-Casey; Ling Shao; William F Byerley
Journal:  Hum Genet       Date:  2006-04-08       Impact factor: 4.132

Review 4.  Human genetics of common mycobacterial infections.

Authors:  Natascha Remus; Alexandre Alcaïs; Laurent Abel
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.